However, it is always important to consider whether a therapeutic intervention–e.g., vitamin D3 to treat vitamin D deficiency, might cause an unexpected negative side-effect–in this case an unfavorable CYP3A vitamin D3-mediated drug interaction. The gene discussed is CYP3A4; the disease is vitamin D deficiency.